solution stability, DNA binding, Cytotoxicity, structure-property relationship, topoisomerase inhibition
Anticancer, Ru(II) complexes, X-ray crystal structures, Cytotoxicity, DNA binding, Fluorescence lifetime
Anticancer drugs, Indolo[2, 3-c]quinolines, Schiff bases, Copper(II) complexes, Antiproliferative activity, DNA intercalation, ROS generation, mitochondrial dysfunction, LDH release, Apoptosis
lanthanide, cationic heteroleptic complexes, carbacylamidophosphate, sulfonylamidophosphate, luminescence, crystal structure.